Scarica l'app Stockscreener
3.98
150.31%
2.39
Dopo l'orario di chiusura:
3.50
-0.48
-12.06%
Precedente Chiudi:
$1.59
Aprire:
$1.58
Volume 24 ore:
32.47M
Relative Volume:
44.81
Capitalizzazione di mercato:
$225.27M
Reddito:
-
Utile/perdita netta:
$-131.52M
Rapporto P/E:
-2.236
EPS:
-1.78
Flusso di cassa netto:
$-107.56M
1 W Prestazione:
+132.75%
1M Prestazione:
+170.75%
6M Prestazione:
+348.50%
1 anno Prestazione:
+220.97%
Intervallo 1D:
$1.43
$4.22
Intervallo di 1 settimana:
$1.43
$4.22
Portata 52W:
$0.6101
$4.22
Prelude Therapeutics Inc Stock (PRLD) Company Profile
Nome
Prelude Therapeutics Inc
Settore
Industria
Telefono
(302) 467-1280
Indirizzo
175 INNOVATION BOULEVARD, WILMINGTON
Confronta PRLD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRLD
Prelude Therapeutics Inc
|
3.98 | 89.99M | 0 | -131.52M | -107.56M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Prelude Therapeutics Inc Stock (PRLD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-09-19 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-06-20 | Downgrade | Barclays | Equal Weight → Underweight |
| 2024-03-13 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-02-20 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-12-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-11-21 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-09-09 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2022-07-29 | Iniziato | Jefferies | Buy |
| 2022-03-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-28 | Downgrade | Barclays | Overweight → Equal Weight |
| 2021-10-08 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-07-27 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-04-26 | Iniziato | H.C. Wainwright | Buy |
| 2021-03-09 | Iniziato | Barclays | Overweight |
| 2020-11-20 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-10-20 | Iniziato | BofA Securities | Buy |
| 2020-10-20 | Iniziato | Goldman | Neutral |
| 2020-10-20 | Iniziato | Morgan Stanley | Equal-Weight |
Mostra tutto
Prelude Therapeutics Inc Borsa (PRLD) Ultime notizie
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.51% - Investing.com
Prelude Therapeutics (PRLD) to Present Preclinical Findings at A - GuruFocus
Can Prelude Therapeutics Incorporated stock hit analyst price targetsDay Trade & Real-Time Price Movement Reports - newser.com
Is Prelude Therapeutics Incorporated stock ready for a breakoutQuarterly Trade Review & High Accuracy Trade Alerts - newser.com
Prelude Therapeutics Announces Publication of Abstracts for Presentation at the American Society of Hematology 67th Annual Meeting - Yahoo Finance
Pattern recognition hints at Prelude Therapeutics Incorporated upsideJuly 2025 Market Mood & Stepwise Swing Trade Plans - newser.com
What to do if you’re stuck in Prelude Therapeutics IncorporatedJuly 2025 Weekly Recap & Safe Swing Trade Setups - newser.com
What institutional flow reveals about Prelude Therapeutics Incorporated2025 Trading Recap & Daily Profit Maximizing Tips - newser.com
How Prelude Therapeutics Incorporated stock reacts to oil pricesJuly 2025 Movers & High Accuracy Swing Entry Alerts - newser.com
Is Prelude Therapeutics Incorporated stock a defensive play in 2025Quarterly Portfolio Summary & Weekly Setup with High ROI Potential - newser.com
Volume spikes in Prelude Therapeutics Incorporated stock – what they meanJuly 2025 Recap & Technical Pattern Based Buy Signals - newser.com
Will Prelude Therapeutics Incorporated stock deliver shareholder valueJuly 2025 Retail & Daily Oversold Bounce Ideas - newser.com
Can Prelude Therapeutics Incorporated stock maintain operating marginsJuly 2025 Snapshot & Consistent Income Trade Recommendations - newser.com
Is Prelude Therapeutics Incorporated stock supported by strong fundamentalsPortfolio Performance Report & High Return Trade Guides - newser.com
Is Prelude Therapeutics Incorporated stock supported by innovation pipelineBear Alert & AI Enhanced Trade Execution Alerts - newser.com
Prelude Therapeutics Shares Surge on Analyst Optimism and Upcoming Earnings - AD HOC NEWS
Prelude Therapeutics Incorporat (PRLD) stock forecast and price target - Yahoo! Finance UK
What sentiment indicators say about Prelude Therapeutics Incorporated stockWatch List & Verified Technical Trade Signals - newser.com
Using flow based indicators on Prelude Therapeutics IncorporatedDip Buying & Safe Entry Zone Tips - newser.com
How to build a custom watchlist for Prelude Therapeutics Incorporated2025 Investor Takeaways & Weekly Momentum Picks - newser.com
Can Prelude Therapeutics Incorporated stock sustain free cash flow growthWeekly Profit Report & Long-Term Safe Return Strategies - newser.com
Prelude Therapeutics Inc expected to post a loss of 37 cents a shareEarnings Preview - TradingView
What machine learning models say about Prelude Therapeutics IncorporatedTrend Reversal & Reliable Trade Execution Plans - newser.com
Exit strategy if you’re trapped in Prelude Therapeutics IncorporatedJuly 2025 Action & Risk Controlled Swing Trade Alerts - newser.com
How Prelude Therapeutics Incorporated stock performs in interest rate cyclesInflation Watch & Free Expert Verified Stock Movement Alerts - newser.com
Real time alert setup for Prelude Therapeutics Incorporated performanceInsider Selling & Free Daily Entry Point Trade Alerts - newser.com
Prelude Therapeutics Incorporated (PRLD) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Prelude Therapeutics Incorporated (PRLD) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Real time pattern detection on Prelude Therapeutics Incorporated stock2025 Technical Overview & Low Drawdown Investment Strategies - newser.com
How moving averages guide Prelude Therapeutics Incorporated trading2025 Key Highlights & AI Forecast for Swing Trade Picks - newser.com
Prelude Therapeutics Inc Azioni (PRLD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):